新兴的非病毒载体用于基因传递
Chenfei Wang1, Chaolan Pan1, Haiyang Yong2
1Department of Dermatology, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai, 201102, China.
Journal of nanobiotechnology
|August 17, 2023
概括
像脂质纳米颗粒这样的非病毒基因传递载体为基因治疗提供了有希望的解决方案. 本综述详细介绍了使用这些新型基因传递系统的进展,挑战和批准的治疗方法.
科学领域:
- 生物医学是生物医学.
- 分子生物学分子生物学
- 材料科学 材料科学 材料科学
背景情况:
- 基因疗法旨在通过将功能基因输入细胞来治疗疾病.
- 临床基因疗法受到缺乏安全有效的基因输送载体的阻碍.
研究的目的:
- 审查新型,快速增长和高效的非病毒基因传递载体.
- 讨论研究进展,发展方向和这些载体的挑战.
- 提供已批准的非病毒基因疗法和临床试验的概述.
主要方法:
- 关于非病毒基因传递系统的综合文献综述.
- 分析研究进展和载体的潜在发展.
- 目前临床应用和试验的概述.
主要成果:
- 确定了关键的非病毒载体:脂质体,脂质纳米粒子 (LNPs),多β-氨基 (HPAE),单链循环聚合物 (SCKP),多胺胺 (PAMAM) 树突体和聚乙烯胺 (PEI).
- 对每个载体类型的详细研究进展,未来方向和现有挑战.
- 总结了目前批准的非病毒基因疗法和正在进行的临床试验.
结论:
- 非病毒基因载体对于推进临床基因治疗至关重要.
- 材料科学和分子生物学领域的持续研究将提高基因传递效率和安全性.
- 非病毒载体在临床基因疗法的不断扩大的领域中越来越重要.
相关概念视频
Microorganisms in Medicine and Therapeutics
54
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
54
Gene Therapy
25.5K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.5K


